Countdown to 2021 CBIIC:

Stephen LIN

Partner of Lilly Asia Ventures

Stephen Lin, M.S., MBA

Stephen, the Partner at Lilly Asia Ventures, focuses on venture investment in healthcare industries. He serves on the Board of several companies, including Sinqi Pharma, CanSino, ACEA,Kawin, MabSpace and Sansure Biotech. Before that, he worked as BD at GlaxoSmithKline (Great China), covering M&A and product licensing. Previously, he managed the marketing of a core product at Merck Serono (China). In Sanjiu Medical & Pharmaceutical, he set up and headed the Strategic Planning Department, driving corporate strategic planning and business development.


Stephen’s education includes a Master of Science in Medicinal Chemistry and a Bachelor of Pharmaceutical Chemistry, both from China Pharmaceutical University. He also earned a Master of Business Administration degree (finance direction) from China Europe International Business School. A Licensed Pharmacist in China.